Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Hypertrophic And Keloid Scar Treatment Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The hypertrophic and keloid scar treatment market has shown strong expansion in recent years. This market is expected to increase from $8.49 billion in 2025 to $9.33 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. The historical period’s growth is attributable to an increasing number of surgical procedures, a rising incidence of trauma and burns, the widespread application of corticosteroid injections, the growth of dermatology and cosmetic clinics, and the clearly visible aesthetic impact of scars.
The hypertrophic and keloid scar treatment market is projected to experience substantial expansion in the coming years. This market is set to reach a value of $13.77 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.2%. Factors contributing to this growth during the forecast period include an increasing preference for non-invasive scar interventions, wider adoption of laser and radiotherapy methods, greater understanding of the importance of early scar management, the development of combination treatment approaches, and improved accessibility to specialized dermatology services. Key trends anticipated in the same period involve a heightened uptake of combination scar management therapies, a growing inclination towards minimally invasive and non-surgical treatments, the increased application of laser and energy-based scar revision technologies, the broadening of post-surgical and preventive scar care offerings, and an enhanced emphasis on early intervention alongside long-term scar control.
Get A Free Sample Report With In-Depth Market Insights:
Hypertrophic And Keloid Scar Treatment Market Development Factors: What’s Supporting Demand?
The hypertrophic and keloid scar treatment market is projected to expand due to a rise in road accidents and burn cases. Road accidents are defined as incidents occurring on the road that involve at least one vehicle and individuals. Both road accidents and burn cases demand careful attention and suitable measures for prevention and effective treatment. Hypertrophic and keloid scar treatments are utilized for those injured in road accidents, helping to reduce the height and tightness of scars. The increasing occurrence of road accidents and burn cases directly contributes to the growth of the hypertrophic and keloid scar treatment market. For example, as reported by The Health Foundation, a UK-based independent organization, in January 2025, data from 2023 showed 43 serious or fatal casualties per billion miles traveled by car, in contrast to 1,032 for cyclists and 1,914 for motorcyclists, while 92 pedestrians per million residents sustained fatal or serious injuries. Thus, the escalating number of road accidents and burn cases will propel the hypertrophic and keloid scar treatment market.
Hypertrophic And Keloid Scar Treatment Market Segment Outlook: Which Categories Are Growing Fastest?
The hypertrophic and keloid scar treatment market covered in this report is segmented –
1) By Treatment: Cryotherapy, Surgical Excision, Pressure Dressings, Intralesional 5-Fluorouracil, Superficial X-Ray, Intralesional Corticosteroid Injection, Other Treatments
2) By Products: Topical Products, Laser Products, Injectables, Other Products
3) By Scar: Hypertrophic Scars, Keloid Scars
4) By End-Use: Hospitals, Clinics, Other End-Users
Subsegments:
1) By Cryotherapy: Liquid Nitrogen Cryotherapy, Intralesional Cryotherapy
2) By Surgical Excision: Simple Excision, Excision With Skin Grafting
3) By Pressure Dressings: Elastic Bandage Pressure Dressings, Silicone Gel Pressure Dressings
4) By Intralesional 5-Fluorouracil: Standalone 5-FU Treatment, Combination With Corticosteroids
5) By Superficial X-Ray: Low-Dose X-Ray Therapy, Combination X-Ray With Other Treatments
6) By Intralesional Corticosteroid Injection: Triamcinolone Acetonide Injection, Combination With 5-Fluorouracil
7) By Other Treatments: Laser Therapy, Radiotherapy, Interferon Therapy
Hypertrophic And Keloid Scar Treatment Market Transformation Trends: What Innovations Are Driving Change?
Leading companies in the hypertrophic and keloid scar treatment market are prioritizing the development of clinically validated silicon-based solutions, such as medical-grade silicone strips, to maximize their market profitability. Medical-grade silicone strips are therapeutic products crafted from high-quality silicone material, specifically formulated to encourage scar healing and reduction. For instance, in April 2023, Scar Erase, a UK-based firm offering silicone-based scar reduction therapy, introduced Scar Erase silicone strips, a clinically tested and affordable option for scar recovery. Constructed from 3mm of medical-grade silicone, these strips aid in treating various scar types, including hypertrophic, keloid, post-surgery, and stretch marks. This silicone technology effectively envelops the scar area, promoting hydration and an optimal healing environment, which leads to significant improvements in scar texture, color, and height. It is designed for comfort and discretion, offering an accessible at-home solution for scar treatment.
Hypertrophic And Keloid Scar Treatment Market Leading Companies And Competitive Benchmarking
Major companies operating in the hypertrophic and keloid scar treatment market are Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Stratpharma AG, Biodermis, Mederma, Silagen
View The Full Hypertrophic And Keloid Scar Treatment Market Report:
Hypertrophic And Keloid Scar Treatment Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the hypertrophic and keloid scar treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
